Palisade Bio
PALI
10 hedge funds and large institutions have $956K invested in Palisade Bio in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 5 → 10 (+5)
0% more ownership
Funds ownership: 0% → 0% (+0%)
21% less capital invested
Capital invested by funds: $1.21M → $956K (-$258K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$976K |
| 2 |
AC
Armistice Capital
New York
|
+$402K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$57.4K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$57.4K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$57.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$230K |
| 2 |
VF
Virtu Financial
New York
|
-$26K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$23K |
| 4 |
ML
McAdam LLC
Philadelphia,
Pennsylvania
|
-$4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$3K |
PALI Hedge Fund Activity: Q4 2018 in Review
10 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2018, worth a combined $956K — down 21% from $1.21M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PALI positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $976K. The largest seller was Vanguard Group, cutting an estimated $230K.
- 10 institutional investors held Palisade Bio (PALI) as of Q4 2018, up from 5 in Q3 2018.
- Funds reported $956K of Palisade Bio stock for Q4 2018, down 21% quarter-over-quarter.
- 5 funds opened new Palisade Bio positions in Q4 2018 and 0 closed out, a net change of +5 holders.
- The largest Palisade Bio buyer in Q4 2018 was Sabby Management, an estimated $976K added.
- The largest Palisade Bio seller in Q4 2018 was Vanguard Group, an estimated $230K sold.
Based on aggregated 13F filings for Q4 2018.